Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.52% |
| 2 | Technology | 7.24% |
| 3 | Financials | 6.69% |
| 4 | Healthcare | 6.46% |
| 5 | Industrials | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Repay Holdings
RPAY
$313M
| $9.24M | ﹤0.01% |
625,882
+16,691
| +3% | +$276K |
|
2202
Karyopharm Therapeutics
KPTI
$44M
| $9.23M | ﹤0.01% |
83,525
-17,823
| -18% | -$2.22M |
|
2203
The Greenbrier Companies
GBX
$1.43B
| $9.21M | ﹤0.01% |
178,893
-198,395
| -53% | -$8.94M |
|
2204
Transocean
RIG
$6.41B
| $9.21M | ﹤0.01% |
2,014,996
-5,678,290
| -74% | -$21.6M |
|
2205
MillerKnoll
MLKN
$1.6B
| $9.21M | ﹤0.01% |
266,355
+197,189
| +285% | +$7.27M |
|
2206
Lennox International
LII
$13.5B
| $9.19M | ﹤0.01% |
35,623
-121,548
| -77% | -$33.4M |
|
|
SDST
2207
Stardust Power Inc
SDST
$5.37M
| $9.19M | ﹤0.01% |
93,437
-7,685
| -8% | -$750K |
|
2208
PUT
Sony
SONY
$141B
| $9.18M | ﹤0.01% |
447,000
| – | – |
|
2209
PUT
Fluor
FLR
$7.24B
| $9.18M | ﹤0.01% |
320,000
| – | – |
|
2210
Empire State Realty Trust
ESRT
$803M
| $9.16M | ﹤0.01% |
933,313
+358,656
| +62% | +$3.38M |
|
2211
AXIS Capital
AXS
$7.23B
| $9.16M | ﹤0.01% |
151,515
-639,523
| -81% | -$35.6M |
|
2212
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
| $9.16M | ﹤0.01% |
26,409
-42,595
| -62% | -$14.8M |
|
|
PACX
2213
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
| $9.15M | ﹤0.01% |
932,661
-661,397
| -41% | -$6.48M |
|
2214
ENI
E
$76.7B
| $9.13M | ﹤0.01% |
+312,161
| New | +$9.29M |
|
2215
S&T Bancorp
STBA
$1.76B
| $9.13M | ﹤0.01% |
+308,534
| New | +$9.69M |
|
2216
FuboTV Inc
FUBO
$305M
| $9.1M | ﹤0.01% |
+115,375
| New | +$13.5M |
|
|
GIIX
2217
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
| $9.1M | ﹤0.01% |
914,051
+263,626
| +41% | +$2.63M |
|
|
LFTR
2218
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
| $9.09M | ﹤0.01% |
923,283
| – | – |
|
|
DHBC
2219
DELISTED
DHB Capital Corp. Class A common stock
DHBC
| $9.09M | ﹤0.01% |
930,817
+661,887
| +246% | +$6.44M |
|
|
HWEL
2220
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
| $9.08M | ﹤0.01% |
937,052
+7,052
| +0.8% | +$67.9K |
|
|
DNZ
2221
DELISTED
D and Z Media Acquisition Corp.
DNZ
| $9.06M | ﹤0.01% |
925,703
+36
| +0% | +$351 |
|
2222
AMC Global Media
AMCX
$509M
| $9.03M | ﹤0.01% |
222,229
+31,545
| +17% | +$1.27M |
|
|
RYZ
2223
Ryerson Holding Corp
RYZ
$1.33B
| $9.02M | ﹤0.01% |
257,535
+60,399
| +31% | +$1.64M |
|
2224
RLX Technology
RLX
$2.2B
| $9.02M | ﹤0.01% |
+5,036,419
| New | +$15M |
|
2225
Stoke Therapeutics
STOK
$2.1B
| $9.01M | ﹤0.01% |
427,997
+278,372
| +186% | +$5.57M |
|
Similar funds
Israel Englander's Q1 2022 Portfolio in Review
As of Q1 2022, Israel Englander held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Israel Englander's Q1 2022 filing shows 1,491 new, 2,450 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 58% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Israel Englander added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Israel Englander's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Israel Englander fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Israel Englander's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Israel Englander opened 1,491 new positions and closed 1,365 in Q1 2022.
- Israel Englander's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.